Case Name: Prometheus Labs, Inc. v. Roxane Labs, Inc., Case Nos. 11-230 (FSH), 11-1241 (FSH), Unpublished (D.N.J. May 21, 2014) (Hochberg, J.) Drug Product and Patent ...
Real‑world and prospective data demonstrate the role of clearance‑informed, precision‑guided dosing in supporting individualized treatment decisions and durable disease control Data from two studies ...
As co-chief executive of the start-up Prometheus, the Amazon founder is using A.I. to improve how devices ranging from ...
SAN DIEGO, July 31, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the market launch of its proprietary new generation monitoring ...
SAN DIEGO, Sept. 14 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the appointment of Dr. Declan Doogan as Executive Vice President ...
Firm’s newly established business will use purchase to move into gastrointestinal testing. Nestlé’s recently established Nestlé Health Science operation will acquire specialty pharmaceutical and ...
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Rosetta Genomics Ltd. (Nasdaq: ROSG), an innovative molecular diagnostic company, today announced the execution of ...
SAN DIEGO, March 28, 2017 /PRNewswire/ -- Prometheus Laboratories Inc.—a Nestlé Health Science company—announces the launch of IBcause™, an all-in-one convenient test that evaluates a unique ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results